Fig. 10From: Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysisForest plots for HCV Ab prevalence in PWID by official period of harm reduction. a Before 2005; b during and after 2005Back to article page